Lamivudine for hepatitis B after liver transplantation
Author:
- 1 June 2001
- journal article
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 7 (6) , 511-512
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Adefovir dipivoxil for the treatment of lamivudine-resistant hepatitis B mutantsHepatology, 2000
- LAMIVUDINE FOR HEPATITIS B IN LIVER TRANSPLANTATIONTransplantation, 2000
- Outcome of lamivudine resistant hepatitis B virus infection in the liver transplant recipientGut, 2000
- Long-term incidence of hepatitis B virus resistance to lamivudine in human immunodeficiency virus-infected patientsHepatology, 1999
- Selection of hepatitis B surface “escape” mutants during passive immune prophylaxis following liver transplantation: potential impact of genetic changes on polymerase protein functionGut, 1999
- Susceptibility of lamivudine-resistant hepatitis B virus to other reverse transcriptase inhibitorsJournal of Clinical Investigation, 1999
- Multicenter Study of Lamivudine Therapy for Hepatitis B After Liver TransplantationHepatology, 1999
- Mutations in Hepatitis B Dna Polymerase Associated With Resistance to Lamivudine Do Not Confer Resistance to Adefovir In VitroHepatology, 1998
- Lamivudine treatment for acute hepatitis B after liver transplantationJournal of Hepatology, 1998
- Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulinHepatology, 1998